MMP14 and glioblastoma: The collective results from these preliminary NIRF and PET in situ resection experiments support the conclusion that mid-resection imaging with the MMP-14 targeted peptide probes enables detection of partially resected GBM xenograft regions remaining in the surgical cavity.